Attached files
file | filename |
---|---|
EX-32.1 - EX-32.1 - RADIENT PHARMACEUTICALS Corp | a56178exv32w1.htm |
10-Q - FORM 10-Q - RADIENT PHARMACEUTICALS Corp | a56178e10vq.htm |
EX-31.2 - EX-31.2 - RADIENT PHARMACEUTICALS Corp | a56178exv31w2.htm |
EX-31.1 - EX-31.1 - RADIENT PHARMACEUTICALS Corp | a56178exv31w1.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of Radient Pharmaceuticals Corporation (the Company)
on Form 10-Q for the period ended March 31, 2010 as filed with the Securities and Exchange
Commission on the date hereof (the Report), I, Akio Ariura, Chief Financial Officer and Secretary
of the Company, certify, pursuant to Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of
the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
Date: May 24, 2010 | /s/ Akio Ariura | |||
Akio Ariura | ||||
Chief Financial Officer and Secretary Radient Pharmaceuticals Corporation |
||||
A signed original of this written statement required by Section 906 has been provided to
the Company and will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.
This certification accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed
filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the Exchange Act). Such certification will not be deemed to be incorporated by reference into
any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent
that the Company specifically incorporates it by reference.